Identifying new proteins and genes in head and neck cancer
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
This study is trying to find new proteins and genes in head and neck cancer to help create better treatments and diagnosis for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Stanford, California) |
| Trial ID | NCT00230308 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the mechanisms that contribute to the development and progression of head and neck cancer. By analyzing patients undergoing surgery at Stanford University, researchers hope to identify novel proteins and genes associated with this type of cancer. The long-term goal is to develop new strategies and drugs for better diagnosis and treatment options for patients with head and neck cancer.
Who should consider this trial
Good fit: Ideal candidates are patients undergoing surgery for head and neck cancer at Stanford University.
Not a fit: Patients who are not undergoing surgery or are treated outside of Stanford University will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and targeted therapies for head and neck cancer patients.
How similar studies have performed: Other studies have shown success in identifying biomarkers in cancer, suggesting potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients undergoing surgery at Stanford University for head and neck cancer. Exclusion Criteria: Non-Stanford patients.
Where this trial is running
Stanford, California
- Stanford University School of Medicine — Stanford, California, United States (Recruiting)
Study contacts
- Principal investigator: John B Sunwoo — Stanford University
- Study coordinator: Nikita Bedi
- Email: nbedi@stanford.edu
- Phone: 650-723-5957
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.